Valuation: Bioadaptives Inc

Market Cap 77.98K 67.79K 63.1K 57.93K 109K 7.44M 111K 744K 292K 3.71M 293K 286K 12.43M P/E 2024
-0.55x
P/E 2025 -0.14x
Enterprise Value 304K 264K 246K 226K 426K 29.02M 433K 2.9M 1.14M 14.45M 1.14M 1.12M 48.44M EV / Sales 2024
55.1x
EV / Sales 2025 26.9x
Free-Float
82.58%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 55 2024-05-20
Investor Relations Contact - -
Corporate Officer/Principal 63 -
Director TitleAgeSince
Director/Board Member 53 2024-05-29
Chairman 55 2024-05-20
Director/Board Member 70 2025-02-02
Change 5-day change 1-year change 3-year change Capi.($)
+1.45%+0.45% - - 77.98K
+1.53%+2.42%+36.94%+87.16% 13.64B
-4.47%-1.57%-32.80%+247.84% 7.84B
-1.15%+6.39%-12.91%-51.30% 2.59B
+3.19%-3.44%-76.47%-64.72% 1.44B
+2.38%+4.39%+33.14%-32.15% 1.29B
+1.13%+8.25%-27.84%-23.48% 1.28B
+0.17%+1.17%+22.88%+37.47% 1.22B
+0.58%-4.57%-37.12% - 1.12B
+9.04%+2.49%-64.37%-71.65% 901M
Average +1.39%+0.92%-17.62%+16.15% 3.48B
Weighted average by Cap. +0.03%+0.86%+1.24%+93.23%

Financials

2024 2025
Net sales 12.67K 11.01K 10.25K 9.41K 17.77K 1.21M 18.05K 121K 47.42K 602K 47.58K 46.53K 2.02M 18.28K 15.89K 14.79K 13.58K 25.64K 1.74M 26.04K 174K 68.42K 869K 68.64K 67.14K 2.91M
Net income -899K -782K -728K -668K -1.26M -85.83M -1.28M -8.58M -3.37M -42.73M -3.38M -3.3M -143M -1.56M -1.35M -1.26M -1.16M -2.19M -149M -2.22M -14.86M -5.83M -74.04M -5.85M -5.72M -248M
Net Debt 206K 179K 166K 153K 288K 19.63M 293K 1.96M 770K 9.77M 772K 755K 32.77M 226K 196K 183K 168K 317K 21.57M 322K 2.16M 846K 10.74M 849K 830K 36.01M
Logo Bioadaptives Inc
BioAdaptives, Inc. operates in the health and wellness industry. The Company’s core business is to investigate, market and distribute natural plant, fungi, and algal based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products in development include a weight management supplement in a human clinical trial, Zeranovia. Zeranovia is made of natural ingredients and uses proprietary methods of optimizing the availability of nutrients in foods and beverages. Xcellara regenerative stem cell activator is in production. Xcellara is its regenerative wellness solution, to enhance performance, accelerate recovery, and revitalize health. PawPa Regen is the canine treat stem cell activator. PawPa Regen supports anti-aging and wellness. Its other products include MyndMed and Wynovia. MyndMed is designed to optimize multiple neurotransmitter systems and neuroprotective pathways.
Employees
-